Total Payments
$34,337
2024 Payments
$2,797
Companies
59
Transactions
994
Medicare Patients
5,183
Medicare Billing
$942,315
Payment Breakdown by Category
Food & Beverage$27,440 (79.9%)
Travel$6,471 (18.8%)
Research$224.28 (0.7%)
Education$202.44 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $27,440 | 964 | 79.9% |
| Travel and Lodging | $6,471 | 22 | 18.8% |
| Unspecified | $224.28 | 2 | 0.7% |
| Education | $202.44 | 6 | 0.6% |
Payments by Type
General
$34,113
992 transactions
Research
$224.28
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABIOMED | $5,973 | 67 | $0 (2024) |
| Abbott Laboratories | $3,468 | 92 | $0 (2024) |
| Medtronic Vascular, Inc. | $3,160 | 33 | $0 (2020) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $2,359 | 41 | $0 (2024) |
| Edwards Lifesciences Corporation | $2,344 | 143 | $0 (2024) |
| Cardiovascular Systems Inc. | $2,206 | 21 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $1,427 | 99 | $0 (2024) |
| Amgen Inc. | $1,211 | 66 | $0 (2024) |
| Boston Scientific Corporation | $1,200 | 18 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,099 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,797 | 86 | Abbott Laboratories ($400.17) |
| 2023 | $2,901 | 107 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($394.49) |
| 2022 | $4,303 | 125 | Endologix LLC ($611.97) |
| 2021 | $3,904 | 92 | ABIOMED ($831.44) |
| 2020 | $2,754 | 88 | ABIOMED ($809.26) |
| 2019 | $6,559 | 163 | ABIOMED ($1,732) |
| 2018 | $2,866 | 152 | ABIOMED ($1,170) |
| 2017 | $8,254 | 181 | Cardiovascular Systems Inc. ($1,951) |
All Payment Transactions
994 individual payment records from CMS Open Payments — Page 1 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Cardiology | ||||||
| 12/17/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: NEUROLOGY | ||||||
| 12/16/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/10/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/04/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Heart Failure | ||||||
| 12/02/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/19/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | Boston Scientific Corporation | ELUVIA (Device) | Food and Beverage | In-kind items and services | $145.33 | General |
| Category: ELUVIA_PI | ||||||
| 11/04/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $26.97 | General |
| 11/04/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.22 | General |
| 10/23/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $137.53 | General |
| Category: Neuromodulation | ||||||
| 10/23/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.29 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/22/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/11/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $49.06 | General |
| Category: Lithoplasty | ||||||
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: DIABETES | ||||||
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.25 | General |
| Category: Cardiovascular | ||||||
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.15 | General |
| Category: Cardiovascular | ||||||
| 09/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: DIABETES | ||||||
| 09/24/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $29.68 | General |
| 09/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Obesity | ||||||
| 09/17/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: Heart Failure | ||||||
| 09/16/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: Heart Failure | ||||||
Research Studies & Clinical Trials
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,680 | 3,092 | $1.3M | $382,695 |
| 2022 | 18 | 1,292 | 2,314 | $809,056 | $222,423 |
| 2021 | 19 | 1,320 | 2,266 | $826,595 | $188,544 |
| 2020 | 13 | 891 | 1,660 | $588,565 | $148,654 |
Total Patients
5,183
Total Services
9,332
Medicare Billing
$942,315
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 349 | 1,174 | $293,500 | $112,390 | 38.3% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 51 | 51 | $252,450 | $100,256 | 39.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 229 | 271 | $272,275 | $40,061 | 14.7% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 51 | 51 | $42,330 | $33,187 | 78.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 231 | 327 | $70,790 | $32,201 | 45.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 51 | 173 | $34,400 | $11,055 | 32.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 19 | 53 | $21,200 | $8,738 | 41.2% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 16 | 19 | $88,500 | $8,039 | 9.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 56 | 56 | $18,720 | $7,312 | 39.1% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 53 | 212 | $7,236 | $5,146 | 71.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 273 | 388 | $35,465 | $4,483 | 12.6% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 20 | 20 | $49,500 | $3,775 | 7.6% |
| 93241 | Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 15 | 15 | $12,375 | $3,210 | 25.9% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 57 | 57 | $34,000 | $3,149 | 9.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 20 | 20 | $12,275 | $3,050 | 24.9% |
| 78434 | Nuclear medicine study of heart muscle blood flow by pet | Office | 2023 | 16 | 16 | $3,200 | $2,366 | 73.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 35 | 44 | $5,500 | $1,378 | 25.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 16 | $2,200 | $1,104 | 50.2% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 54 | 57 | $13,620 | $576.21 | 4.2% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 41 | 45 | $19,740 | $520.38 | 2.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 16 | 16 | $2,540 | $460.84 | 18.1% |
| 99422 | Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | Office | 2023 | 11 | 11 | $2,090 | $237.30 | 11.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 260 | 851 | $212,750 | $70,458 | 33.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 209 | 236 | $229,150 | $36,724 | 16.0% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2022 | 17 | 17 | $84,150 | $32,774 | 38.9% |
About Dr. Samar Sheth, MD
Dr. Samar Sheth, MD is a Cardiovascular Disease healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2009. The National Provider Identifier (NPI) number assigned to this provider is 1013146901.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samar Sheth, MD has received a total of $34,337 in payments from pharmaceutical and medical device companies, with $2,797 received in 2024. These payments were reported across 994 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($27,440).
As a Medicare-enrolled provider, Sheth has provided services to 5,183 Medicare beneficiaries, totaling 9,332 services with total Medicare billing of $942,315. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Nuclear Cardiology, Internal Medicine
- Location Houston, TX
- Active Since 07/13/2009
- Last Updated 04/29/2017
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1013146901
Products in Payments
- Impella (Device) $5,973
- LifeVest (Device) $2,359
- Peripheral Orbital Atherectomy System (Device) $2,014
- CoreValve Evolut (Device) $1,613
- ClosureFast (Device) $1,416
- XARELTO (Drug) $1,410
- Mitra Clip system (Device) $1,286
- ELIQUIS (Drug) $968.54
- ENTRESTO (Drug) $860.37
- Repatha (Biological) $794.19
- Alto Abdominal Stent Graft System (Device) $583.70
- BRILINTA (Drug) $495.57
- FARXIGA (Drug) $492.76
- VERQUVO (Drug) $474.40
- Optimizer Smart System (Device) $410.85
- Corlanor (Drug) $407.19
- Accent Pacemaker (Device) $317.92
- CHANTIX (Drug) $303.67
- Ozempic (Drug) $299.89
- HeartWare HVAD (Device) $297.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Houston
Reynolds Delgado, M.d, M.D
Cardiovascular Disease — Payments: $600,466
Cardiovascular Disease $600,466
Dr. Miguel Valderrabano, Md, MD
Cardiovascular Disease — Payments: $471,736
Cardiovascular Disease $471,736
Asif Ali, Md, MD
Cardiovascular Disease — Payments: $461,190
Cardiovascular Disease $461,190
Mr. Mehdi Razavi, Md, MD
Cardiovascular Disease — Payments: $433,792
Cardiovascular Disease $433,792
Dr. Michele Sartori, M.d, M.D
Cardiovascular Disease — Payments: $278,682
Cardiovascular Disease $278,682
Barry Trachtenberg, Md, MD
Cardiovascular Disease — Payments: $273,547
Cardiovascular Disease $273,547